Site-Specific Bioorthogonal Activation of DNAzymes for On-Demand Gene Therapy
Journal of the American Chemical Society · 2023
DOI: 10.1021/jacs.3c05413 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2023. Verfasst von Rong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biomedical Sciences, Hunan Univ…. Hauptthemen laut MEDLINE: DNA, Catalytic. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Science and Technology Program of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biomedical Sciences, Hunan University, Changsha 410082, China.
ORCID-Profile: Zhenkun Wu, Xia Chu, Jian-Hui Jiang
Förderung
- National Key Research and Development Program of China
- Science and Technology Program of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Wang, R., He, W., Yi, X., Wu, Z., Chu, X., & Jiang, J. H. (2023). Site-Specific Bioorthogonal Activation of DNAzymes for On-Demand Gene Therapy. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.3c05413
Vancouver
Wang R, He W, Yi X, Wu Z, Chu X, Jiang JH. Site-Specific Bioorthogonal Activation of DNAzymes for On-Demand Gene Therapy. Journal of the American Chemical Society. 2023. doi:10.1021/jacs.3c05413
BibTeX
@article{Wang2023,
author = {Wang, Rong and He, Wenhan and Yi, Xin and Wu, Zhenkun and Chu, Xia and Jiang, Jian-Hui},
title = {Site-Specific Bioorthogonal Activation of DNAzymes for On-Demand Gene Therapy},
journal = {Journal of the American Chemical Society},
year = {2023},
doi = {10.1021/jacs.3c05413}
}
EUVIMED